2017 Conference

Clinical

Learn about up to date, evidence-based practice issues on treatment, symptom management, unique patient situations, and more.

Business

Get Information and tools to help you support your community oncology practice operations.

Advocacy

Find out how to be an advocate for accessible, affordable care for all cancer patients.

2017 CONFERENCE SCHEDULE

         

CLINICAL TRACK

BUSINESS TRACK

ADVOCACY TRACK

 

WEDNESDAY, APRIL 26, 2017

5:30 – 7:00 PM

Registration & COA President’s Reception

 

THURSDAY, APRIL 27, 2017

6:30 – 7:30 AM

Registration & Buffet Breakfast in the Exhibit Hall

7:30 – 7:55 AM

Conference Opening Day 1: Welcome from the Co-Chairs

– Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network
– David Eagle, MD, Lake Norman Oncology
– Lucio Gordan, MD, Florida Cancer Specialists & Research Institute
– Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology
– Jeffrey Patton, MD, Chief Executive Officer, Tennessee Oncology
– Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders

7:55 – 8:40 AM

Pharmacy Benefit Managers: Profits Over Patients

– Ricky Newton, CPA, Director of Financial Services & Operations, Community Oncology Alliance (Moderator)
– Josh Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network (Moderator)
– Steve D’Amato, BS Pharm, Executive Director, New England Cancer Specialists
– Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt
– Honorable Earl L. “Buddy” Carter, U.S. House of Representatives

8:45 – 9:30 AM

Targeted Therapies & Immunotherapy in Lung Cancer

– Craig Reynolds, MD, Florida Cancer Specialists

 

Panel Discussion:
Early Learnings from the OCM

– Robert Baird, Jr., RN, MSA, CASC, Chief  Executive Officer, Dayton Physicians Network (Moderator)
– Anne Marie Rainey, MSN, RN, CHC, Compliance & Quality Control Officer, Clearview Cancer Institute
– Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants

Cancer Care Advocacy 2017:
CPAN Goals & Objectives

– Rose Gerber, Director of Patient
Advocacy, Community Oncology Alliance

9:45 – 10:30 AM

Keynote Speaker: Scott Hamilton, Olympic Gold Figure Skater Medalist

10:30 – 10:55 AM

Break & Scott Hamilton Q&A/Book Signing in the Exhibit Hall

11:00 – 11:45 AM

Next-Gen Sequencing:
State of the Art in Clinical
Applications

– Howard “Skip” Burris, MD, President, Clinical Operations, Sarah Cannon

PHARMACY SESSION

Pharmacy Accreditation: Needs,
Issues & Practical Considerations

– Josh Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network (Moderator)
– Bob Phelan, RPh, Chief Executive Officer, Cancer Specialists of North Florida  
 – Tim Safley, MBA, Director, DMEPOS, Pharmacy & Sleep, ACHC

Big Data in Cancer Care:
Is the Rubber Meeting the Road?

– Robert Green, MD, Vice President of Clinical Strategy & Senior Medical Director, Flatiron Health

The View from Capitol Hill:
Cancer Care Policy &
COA’s Priorities

– Ted Okon, MBA, Executive Director,
Community Oncology Alliance

11:50 AM – 12:35 PM

Prehabilitation for Cancer Survivors:
Concepts & Evidence for Impairment Driven Rehabilitation

– Julie K. Silver, MD, Associate Professor & Associate Chair for Strategic Initiatives,
Department of Physical Medicine & Rehabilitation, Harvard Medical School

Claims Data: How to Analyze,
Use, Report & Capitalize on It

– Basit Chaudhry, MD, PhD,
Tuple Health

12:35 – 1:30 PM

Lunch & Networking in the Exhibit Hall

1:35 – 2:35 PM

Panel Discussion:
Implementing the Practice Vision for the Now & Future of Community Oncology

– Terrill Jordan, President & Chief Executive Officer, Regional Cancer Care Associates
– Jeffrey F. Patton, MD, Chief Executive Officer, Tennessee Oncology (Moderator)
– Bradley Prechtl, MBA, Chief Executive Officer, Florida Cancer Specialists
– Jeffrey Vacirca, MD, Chief Executive Officer, NSHOA, a division of New York Cancer & Blood Specialists &
President, Community Oncology Alliance

Community Oncology 101:
Why Does the Site of Cancer Care Matter?

– Betty Apt, Patient Advocate,
Northwest Georgia Oncology Centers
– Joseph Lynch, MD,
Warren Clinic Medical Oncology
– Mark Thompson, MD, Past President, Community Oncology Alliance,
The Mark H. Zangmeister Center

2:35 – 3:20 PM

OCM 2.0: The Universal Oncology Payment Model

– Ted Okon, MBA, Executive Director, Community Oncology Alliance
– Kavita Patel, MD, MS, Tuple Health

Community Oncology 201: Pharmacy Benefit Managers & Impact on Cancer Care

– Ray Bailey, RPh, Director of
Pharmacy, Florida Cancer Specialists
– Josh Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network
– Stacey McCullough, PharmD, Senior Vice President, Pharmacy, Tennessee Oncology

3:20 – 3:50 PM

Networking & Refreshments in the Exhibit Hall

3:55 – 4:55 PM

Novel Therapies in Breast Cancer: HER2 Amplified, ER+, TNBC disease

– Joyce O’Shaughnessy, MD, Texas Oncology

Panel Discussion: Update on
New Payer Initiatives in Cancer Care

– Amanda Joseph, MS-HSM, Senior Affordability of Care Strategy Consultant, Healthcare Service Corporation
– Barbara McAneny, MD, Chief Medical Officer, New Mexico Oncology Hematology Consultants
– Bo Gamble, Director of
Strategic Practice Initiative, Community Oncolgy Alliance (Moderator)
– Rene Frick, Senior Director,
Provider Network Innovations &
Partnerships, BCBS of South Carolina
– Kashyap Patel, MD, Carolina Blood & Cancer Care 

Hands-on Workshop:
Effective Advocacy &  Lobbying Congress

– Honorable Ed Whitfield, Formerly U.S. House of Representatives

– Jeff Mortier, Principal, Farragut Partners

5:00 – 5:50 PM

Panel Discussion: Employers Discuss Cancer Care & Payment Models

– Kembre Roberts, Wellness Manager, Southwest Airlines
– Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders (Moderator)
– Brenna Shebel, Director, National Business Group on Health
– John Robinson,  President & Chief Executive Officer, RobinsonBush

5:50 – 6:35 PM

Networking & Refreshments in the Exhibit Hall

 

FRIDAY, APRIL 28, 2017

6:30 – 7:30 AM

Buffet Breakfast in the Exhibit Hall

7:30 – 8:00 AM

Conference Opening Day 2: Update from the Co-Chairs

– Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network
– David Eagle, MD, Lake Norman Oncology
– Lucio Gordan, MD, Florida Cancer Specialists & Research Institute
– Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology
– Jeffrey Patton, MD, Chief Executive Officer, Tennessee Oncology
– Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders

8:00 – 9:00 AM

Washington, DC Update: The Latest Legislative Issues Impacting Cancer Care & Your Practice

– Christian Downs, JD, MHA, Executive Director, Association of Community Cancer Centers
– Bruce Feinberg, DO, Vice President & Chief Medical Officer, Cardinal Health Specialty Solutions
– Deborah Kamin, PhD, Vice President, Policy & Advocacy, ASCO
– Ben Jones, Vice President of Government Relations & Public Policy, McKesson Specialty Health & The US Oncology Network
– Rita Norton, Senior Vice President,  Director of Government Affairs, AmerisourceBergen
– Ted Okon, MBA, Executive Director, Community Oncology Alliance (Moderator)

9:00 – 9:45 AM

Panel Discussion: How Community Oncology is Fueling the Cancer Moonshot

– William Harwin, MD, President & Managing Parter, Florida Cancer Specialists
– Edward Licitra, MD, PhD, Chief Financial Officer & Director of Revenue Cycle Central Jersey Division, Regional Cancer Care Associates
– Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology (Moderator)
– R. Steven Paulson, MD, President, Texas Oncology

9:45 – 10:10 AM

Break & Networking in the Exhibit Hall

10:15 – 11:00 AM

Myeloma Therapies:
New Options & Understanding the
Role of Sequencing & Transplantation

– Paul G. Richardson, MD, Professor of Medicine, Dana-Farber Cancer Institute

 

PHARMACY SESSION

Panel Discussion:
Orals Adherence & Challenges

– Ray Bailey, RPh, Director of
Pharmacy, Florida Cancer Specialists
– Stacey McCullough, PharmD,
Senior Vice President,
Pharmacy, Tennessee Oncology   
– Todd Murphree, PharmD, Ambulatory
Pharmacy Manager, Clearview
Cancer Institute

The Coding Mistress:
Actionable Resolution for the Most
Common Denials In Oncology

– Roberta L. Buell, MBA, Principal,
onPoint Oncology, LLC

Become a Stronger Advocate:
How to Tell Your Story

– Nick Ferreyros,
Director of Communications,
Community Oncology Alliance

11:05 – 11:50 AM

A Genitourinary Cancer Update: New Therapies

– Daniel J. George, MD, Professor of Medicine & Surgery, Duke Cancer Insitute

MACRA, MIPS & APMs: A Common
Sense Approach to Success

– Aaron Lyss, Director of Value-Based Care, Tennesee Oncology
– Kashyap Patel, MD, Carolina Blood
& Cancer Care

11:50 AM – 12:45 PM

Lunch & Networking in the Exhibit Hall

12:50 – 1:35 PM

Low-Grade Non-Hodgkins Lymphoma;
New Therapies & Updates

– Craig Portell, MD, Emily Couric
Clinical Cancer Center

PHARMACY SESSION

In-Office Pharmacy/Dispensing:
Roadblocks & Legal Issues

– Jesse Dresser, Esq.,
Partner, Frier Levitt
– Jonathan E. Levitt, Esq.,
Founding Partner, Frier Levitt

Quantifying Physician Performance:
Defining the Value Equation

– Lalan Wilfong, MD, Texas Oncology

Expanding CPAN:
Plans & Discussion

-Miriam Yvette Jones Atkins, MD,
Augusta Oncology Associates
– Michael Diaz, MD, Vice President, Community Oncology Alliance, Florida Cancer Specialists
– Rose Gerber, Director of Patient Advocacy, Community  Oncology Alliance
– Anthony Scalzo, MD, Hematology-Oncology
Associates of CNY

1:40 – 2:25 PM

Biosimilar Check-up: Availability & Clinical/Financial Issues

– Edward Li, PharmD, MPH, BCOP, Associate Professor,
University of New England College of Pharmacy

Physician Recruitment & Succession
Planning: Practical Steps

– Barbara McAneny, MD, Chief Medical Officer, New Mexico Oncology Hematology Consultants
– Ray Page, DO, PhD, President, The Center for Cancer & Blood Disorders   
– Robin Zon, MD, FACP, FASCO, Michiana Hematology-Oncology (Moderator)

2:30 – 2:50 PM

Conference Wrap-up: Meeting Observations from the Co-Chairs & Audience